Insider · CIK 0001849739
Christobel Selecky
Files at IBRX (ImmunityBio, Inc.). First filing Jan 21, 2026, latest Jul 6, 2026.
In brief
Christobel Selecky files SEC Form 4 as director at IBRX (ImmunityBio, Inc.). Since Jan 21, 2026, Christobel Selecky has reported 0 open-market buys worth $0 and 4 open-market sells worth $3.0M, the latest filed on Jul 6, 2026.
A track record needs three past buys with six months of prices behind them; Christobel Selecky has 0, so none is measured yet.
The newest scored trade: sold $1.4M of IBRX on Jul 1, 2026, filed Jul 6, 2026, scored 40 (moderate), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 4 sells worth $3.0M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IBRX: ImmunityBio, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | ImmunityBio, Inc. | $1.4M 159,478 shares | -100% | +365% from low-20% from high | |
| 38Weak | ImmunityBio, Inc. | $871k 96,722 shares | -101% | +343% from low-24% from high | |
| 21Weak | ImmunityBio, Inc. | $250k 25,000 shares | -100% | +420% from low0% from high | |
| 25Weak | ImmunityBio, Inc. | $438k 75,000 shares | -150% | +192% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 1, 2026 | IBRX IMMUNITYBIO, INC. | 159,478 0.02% of outstanding | $1.4M | Jul 1, 2026 | $871k |
| Jun 30, 2026 | IBRX IMMUNITYBIO, INC. | 1,000 0.00% of outstanding | $8,770 | Jun 30, 2026 | $862k |
| Jun 29, 2026 | IBRX IMMUNITYBIO, INC. | 95,722 0.01% of outstanding | $834k | Jun 29, 2026 | none |
| Feb 23, 2026 | IBRX IMMUNITYBIO, INC | 25,000 0.00% of outstanding | $218k | Feb 23, 2026 | $438k |
| Jan 20, 2026 | IBRX IMMUNITYBIO, INC. | 25,000 0.00% of outstanding | $138k | Jan 20, 2026 | $250k |
| Jan 16, 2026 | IBRX IMMUNITYBIO INC | 50,000 0.01% of outstanding | $198k | Jan 16, 2026 | none |
Transactions
Every row this insider has filed, 28 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Common Stock10b5-1 | +35,064 | $2.98 | $104k | 35,064 | Jul 6, 2026 |
| Jul 1, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Common Stock10b5-1 | +124,414 | $2.99 | $372k | 159,478 | Jul 6, 2026 |
| Jul 1, 2026 | IBRX ImmunityBio, Inc. | SOpen-market sale Common Stock10b5-1 | -159,478 | $9.02 | $1.4M | 0 | Jul 6, 2026 |
| Jul 1, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -35,064 | $0.00 | $0 | 0 | Jul 6, 2026 |
| Jul 1, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -124,414 | $0.00 | $0 | 0 | Jul 6, 2026 |
| Jun 29, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Common Stock10b5-1 | +32,173 | $2.98 | $96k | 32,173 | Jul 1, 2026 |
| Jun 29, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Common Stock10b5-1 | +33,549 | $2.99 | $100k | 65,722 | Jul 1, 2026 |
| Jun 29, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Common Stock10b5-1 | +30,000 | $2.84 | $85k | 95,722 | Jul 1, 2026 |
| Jun 29, 2026 | IBRX ImmunityBio, Inc. | SOpen-market sale Common Stock10b5-1 | -95,722 | $9.01 | $862k | 0 | Jul 1, 2026 |
| Jun 30, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Common Stock10b5-1 | +700 | $2.98 | $2,086 | 700 | Jul 1, 2026 |
| Jun 30, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Common Stock10b5-1 | +300 | $2.99 | $897 | 1,000 | Jul 1, 2026 |
| Jun 30, 2026 | IBRX ImmunityBio, Inc. | SOpen-market sale Common Stock10b5-1 | -1,000 | $9.00 | $9,000 | 0 | Jul 1, 2026 |
| Jun 29, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -32,173 | $0.00 | $0 | 35,764 | Jul 1, 2026 |
| Jun 29, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -33,549 | $0.00 | $0 | 124,714 | Jul 1, 2026 |
| Jun 29, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -30,000 | $0.00 | $0 | 132,786 | Jul 1, 2026 |
| Jun 30, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -700 | $0.00 | $0 | 35,064 | Jul 1, 2026 |
| Jun 30, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -300 | $0.00 | $0 | 124,414 | Jul 1, 2026 |
| Jun 9, 2026 | IBRX ImmunityBio, Inc. | AGrant or award Stock Option (right to buy)derivative | +65,600 | $0.00 | $0 | 65,600 | Jun 10, 2026 |
| Feb 23, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Common Stock10b5-1 | +25,000 | $2.98 | $75k | 25,000 | Feb 24, 2026 |
| Feb 23, 2026 | IBRX ImmunityBio, Inc. | SOpen-market sale Common Stock10b5-1 | -25,000 | $10.00 | $250k | 0 | Feb 24, 2026 |
| Feb 23, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -25,000 | $0.00 | $0 | 67,937 | Feb 24, 2026 |
| Jan 16, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Common Stock10b5-1 | +50,000 | $2.98 | $149k | 50,000 | Jan 21, 2026 |
| Jan 16, 2026 | IBRX ImmunityBio, Inc. | SOpen-market sale Common Stock10b5-1 | -50,000 | $5.00 | $250k | 0 | Jan 21, 2026 |
| Jan 20, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Common Stock10b5-1 | +25,000 | $2.98 | $75k | 25,000 | Jan 21, 2026 |
| Jan 20, 2026 | IBRX ImmunityBio, Inc. | SOpen-market sale Common Stock10b5-1 | -25,000 | $7.51 | $188k | 0 | Jan 21, 2026 |
| Jan 16, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -50,000 | $0.00 | $0 | 117,937 | Jan 21, 2026 |
| Jan 20, 2026 | IBRX ImmunityBio, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -25,000 | $0.00 | $0 | 92,937 | Jan 21, 2026 |
| Jun 18, 2025 | IBRX ImmunityBio, Inc. | AGrant or award Stock Option (right to buy)derivative | +162,786 | $0.00 | $0 | 162,786 | Jun 20, 2025 |
Questions about Christobel Selecky
Answered from the filings on this page, as of the latest one.
Is Christobel Selecky buying or selling?
In the last 12 months Christobel Selecky reported 0 open-market buys worth $0 and 4 open-market sells worth $3.0M on SEC Form 4; the latest was sold $1.4M of IBRX on Jul 1, 2026. Grants, option exercises and tax withholding are not counted.
How did Christobel Selecky's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christobel Selecky has 0.
Where does Christobel Selecky file Form 4?
Christobel Selecky has filed Form 4 at IBRX (ImmunityBio, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.